Barker EA - Search Results

1

IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.

Maier LA, Sawyer RT, Tinkle SS, Kittle LA, Barker EA, Balkissoon R, Rose C, Newman LS. Maier LA, et al. Among authors: barker ea. Eur Respir J. 2001 Mar;17(3):403-15. doi: 10.1183/09031936.01.17304030. Eur Respir J. 2001. PMID: 11405518 Free article.

2

Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease.

Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Maier LA, et al. Among authors: barker ea. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1342-50. doi: 10.1164/ajrccm.159.4.9806106. Am J Respir Crit Care Med. 1999. PMID: 10194187

3

Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.

Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Inoue Y, et al. Am J Respir Crit Care Med. 1997 Jul;156(1):109-15. doi: 10.1164/ajrccm.156.1.9612043. Am J Respir Crit Care Med. 1997. PMID: 9230733

4

Serum neopterin in chronic beryllium disease.

Harris J, Bartelson BB, Barker E, Balkissoon R, Kreiss K, Newman LS. Harris J, et al. Am J Ind Med. 1997 Jul;32(1):21-6. doi: 10.1002/(sici)1097-0274(199707)32:1<21::aid-ajim3>3.0.co;2-u. Am J Ind Med. 1997. PMID: 9131208

5

Mast cell basic fibroblast growth factor in silicosis.

Hamada H, Vallyathan V, Cool CD, Barker E, Inoue Y, Newman LS. Hamada H, et al. Am J Respir Crit Care Med. 2000 Jun;161(6):2026-34. doi: 10.1164/ajrccm.161.6.9812132. Am J Respir Crit Care Med. 2000. PMID: 10852784

6

Developing effective health and safety training materials for workers in beryllium-using industries.

Mayer AS, Brazile WJ, Erb SA, Barker EA, Miller CM, Mroz MM, Maier LA, Van Dyke MV. Mayer AS, et al. Among authors: barker ea. J Occup Environ Med. 2013 Jul;55(7):746-51. doi: 10.1097/JOM.0b013e3182972f1b. J Occup Environ Med. 2013. PMID: 23787563

7

Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT.

Farris GM, Newman LS, Frome EL, Shou Y, Barker E, Habbersett RC, Maier L, Smith HN, Marrone BL. Farris GM, et al. Toxicology. 2000 Feb 21;143(2):125-40. doi: 10.1016/s0300-483x(99)00167-5. Toxicology. 2000. PMID: 10755700

8

A quantitative proteomic analysis of soluble bronchoalveolar fluid proteins from patients with sarcoidosis and chronic beryllium disease.

Silva E, Bourin S, Sabounchi-Schütt F, Laurin Y, Barker E, Newman L, Eriksson H, Eklund A, Grunewald J. Silva E, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2007 Mar;24(1):24-32. Sarcoidosis Vasc Diffuse Lung Dis. 2007. PMID: 18069416

9

The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Dillon SM, Lee EJ, Bramante JM, Barker E, Wilson CC. Dillon SM, et al. J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):259-67. doi: 10.1097/01.qai.0000435603.50598.2b. J Acquir Immune Defic Syndr. 2014. PMID: 24091697 Free PMC article.

10

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.

Barker E, Mackewicz CE, Levy JA. Barker E, et al. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11135-9. doi: 10.1073/pnas.92.24.11135. Proc Natl Acad Sci U S A. 1995. PMID: 7479952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters